Please wait...

Learn

Finding accredited CPD

Chemotherapy Induced Peripheral Neuropathy

Description

Chemotherapy Induced Peripheral Neuropathy (CIPN) is a common issue for GPs in the community. With over 400 patients per day receiving a cancer diagnosis, many patients will receive chemotherapeutic agents, placing them at risk of this condition. Short to medium-term treatment for this common condition can be challenging.

Join Dr Andrea Tazbirkova, Medical Oncologist, as she shares tips and tricks on assessing, managing and treating these common yet complex conditions for those vulnerable patients.


Details

Learning Objectives:

  1. Discuss the incidence and prevalence of Chemotherapy Induced Peripheral Neuropathy (CIPN)
  2. Discuss patients at greatest risk of CIPN
  3. Discuss the identification and management of CIPN in the GP setting.

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard.

Provided by


CPD Activity Details
Topic
General Practice and Primary Care
CAPE Aspects
Professionalism
Effective Year

Educational Activities (EA) - 1.0

Reviewing Performance (RP) - 5.0

Measuring Outcomes (MO) - 1.0

You have to log in to see the content of this module.

*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)